Hepatoprotective effect of rebamipide against methotrexate-induced hepatic intoxication: role of Nrf2/GSK-3β, NF-κβ-p65/JAK1/STAT3, and PUMA/Bax/Bcl-2 signaling pathways

References

• Huennekens FM. The methotrexate story: a paradigm for development of cancer chemotherapeutic agents. Adv Enzyme Regul. 1994;34:397–419.
   PubMedGoogle Scholar
• Howard SC, McCormick J, Pui C-H, et al. Preventing and managing toxicities of high-dose methotrexate. Oncologist. 2016;21(12):1471–1482.
   PubMed Web of Science ®Google Scholar
• Lipsky PE, van der Heijde DMFM, St. Clair EW, et al. Infliximab and methotrexate in the treatment of rheumatoid arthritis. N Engl J Med. 2000;343(22):1594–1602.
   PubMed Web of Science ®Google Scholar
• Bath RK, Brar NK, Forouhar FA, et al. A review of methotrexate-associated hepatotoxicity. J Dig Dis. 2014;15(10):517–524.
   PubMed Web of Science ®Google Scholar
• Kalantar M, Kalantari H, Goudarzi M, et al. Crocin ameliorates methotrexate-induced liver injury via inhibition of oxidative stress and inflammation in rats. Pharmacol Rep. 2019;71(4):746–752.
   PubMed Web of Science ®Google Scholar
• Ahmadzadeh A, Zamani N, Hassanian-Moghaddam H, et al. Acute versus chronic methotrexate poisoning;a cross-sectional study. BMC Pharmacol Toxicol. 2019;20(1):39.
   PubMedGoogle Scholar
• Aleksunes LM, Manautou JE. Emerging role of Nrf2 in protecting against hepatic and gastrointestinal disease. Toxicol Pathol. 2007;35(4):459–473.
   PubMed Web of Science ®Google Scholar
• Okada K, Shoda J, Taguchi K, et al. Nrf2 counteracts cholestatic liver injury via stimulation of hepatic defense systems. Biochem Biophys Res Commun. 2009;389(3):431–436.
   PubMed Web of Science ®Google Scholar
• Wardyn JD, Ponsford AH, Sanderson CM. Dissecting molecular cross-talk between Nrf2 and NF-κB response pathways. Biochem Soc Trans. 2015;43(4):621–626.
   PubMed Web of Science ®Google Scholar
• Cuadrado A, Martín-Moldes Z, Ye J, et al. Transcription factors NRF2 and NF-κB are coordinated effectors of the Rho family, GTP-binding protein RAC1 during inflammation. J Biol Chem. 2014;289(22):15244–15258.
   PubMed Web of Science ®Google Scholar
• Jacobs KM, Bhave SR, Ferraro DJ, et al. GSK-3beta: A Bifunctional Role in Cell Death Pathways. Int J Cell Biol. 2012;2012:930710.
   PubMedGoogle Scholar
• Mahmoud AR, Ali FEM, Abd-Elhamid TH, et al. Coenzyme Q10 protects hepatocytes from ischemia reperfusion-induced apoptosis and oxidative stress via regulation of Bax/Bcl-2/PUMA and Nrf-2/FOXO-3/Sirt-1 signaling pathways. Tissue Cell. 2019;60:1–13.
   PubMed Web of Science ®Google Scholar
• Thompson MD, Monga SP. WNT/beta-catenin signaling in liver health and disease. Hepatology. 2007;45(5):1298–1305.
   PubMed Web of Science ®Google Scholar
• Armagan G, Sevgili E, Gürkan FT, et al. Regulation of the Nrf2 pathway by glycogen synthase kinase-3beta in MPP(+)-induced cell damage. Molecules. 2019;24(7):1377.,
   Web of Science ®Google Scholar
• Salazar M, Rojo AI, Velasco D, et al. Glycogen synthase kinase-3beta inhibits the xenobiotic and antioxidant cell response by direct phosphorylation and nuclear exclusion of the transcription factor Nrf2. J Biol Chem. 2006;281(21):14841–14851.
   PubMed Web of Science ®Google Scholar
• Dugo L, Collin M, Thiemermann C. Glycogen synthase kinase 3beta as a target for the therapy of shock and inflammation. Shock. 2007;27(2):113–123.
   PubMed Web of Science ®Google Scholar
• Zhang H, Wang W, Fang H, et al. GSK-3beta inhibition attenuates CLP-induced liver injury by reducing inflammation and hepatic cell apoptosis. Mediators Inflamm. 2014;2014:629507.
   PubMed Web of Science ®Google Scholar
• Wang Y, Huang WC, Wang CY, et al. Inhibiting glycogen synthase kinase-3 reduces endotoxaemic acute renal failure by down-regulating inflammation and renal cell apoptosis. Br J Pharmacol. 2009;157(6):1004–1013.
   PubMed Web of Science ®Google Scholar
• Arakawa T, Kobayashi K, Yoshikawa T, et al. Rebamipide: overview of its mechanisms of action and efficacy in mucosal protection and ulcer healing. Dig Dis Sci. 1998;43(9 Suppl):5s–13s.
   PubMed Web of Science ®Google Scholar
• Ogino K, Hobara T, Ishiyama H, et al. Antiulcer mechanism of action of rebamipide, a novel antiulcer compound, on diethyldithiocarbamate-induced antral gastric ulcers in rats. Eur J Pharmacol. 1992;212(1):9–13.
   PubMed Web of Science ®Google Scholar
• Arakawa T, Watanabe T, Fukuda T, et al. Rebamipide, novel prostaglandin-inducer accelerates healing and reduces relapse of acetic acid-induced rat gastric ulcer. Comparison with cimetidine. Dig Dis Sci. 1995;40(11):2469–2472.
   PubMed Web of Science ®Google Scholar
• Kim TJ, Kim ER, Hong SN, et al. Effectiveness of acid suppressants and other mucoprotective agents in reducing the risk of occult gastrointestinal bleeding in nonsteroidal anti-inflammatory drug users. Sci Rep. 2019;9(1):11696
   PubMedGoogle Scholar
• Fu R, et al. Rebamipide ophthalmic solution modulates the ratio of T helper cell 17/regulatory T cells in dry eye disease mice. Mol Med Rep. 2019;19(5):4011–4018.
   PubMed Web of Science ®Google Scholar
• Bang BW, Park D, Kwon KS, et al. BST-104, a Water Extract of Lonicera japonica, Has a Gastroprotective Effect via Antioxidant and Anti-Inflammatory Activities. J Med Food. 2019;22(2):140–151.
   PubMed Web of Science ®Google Scholar
• Tajima K, Hattori T, Takahashi H, et al. Rebamipide suppresses TNF-α production and macrophage infiltration in the conjunctiva . Vet Ophthalmol. 2018;21(4):347–352.
   PubMed Web of Science ®Google Scholar
• Mishra A, Krishnamurthy S. Rebamipide mitigates impairments in mitochondrial function and bioenergetics with α-synuclein pathology in 6-OHDA-induced hemiparkinson's model in rats. Neurotox Res. 2019;35(3):542–562.
   PubMed Web of Science ®Google Scholar
• Gendy AM, Abdallah DM, El-Abhar HS. The potential curative effect of rebamipide in hepatic ischemia/reperfusion injury. Naunyn Schmiedebergs Arch Pharmacol. 2017;390(7):691–700.
   PubMed Web of Science ®Google Scholar
• Lee SM, Kim KH. Rebamipide ameliorates hepatic dysfunction induced by ischemia/reperfusion in rats. Eur J Pharmacol. 1995;294(1):41–46.
   PubMed Web of Science ®Google Scholar
• Zakaria S, El-Sisi A. Rebamipide retards CCl4-induced hepatic fibrosis in rats: Possible role for PGE2. J Immunotoxicol. 2016;13(4):453–462.
   PubMed Web of Science ®Google Scholar
• Kurata S, Nakashima T, Osaki T, et al. Rebamipide protects small intestinal mucosal injuries caused by indomethacin by modulating intestinal microbiota and the gene expression in intestinal mucosa in a rat model. J Clin Biochem Nutr. 2015;56(1):20–27.
   PubMed Web of Science ®Google Scholar
• Khalifa MMA, Bakr AG, Osman AT. Protective effects of phloridzin against methotrexate-induced liver toxicity in rats. Biomed Pharmacother. 2017;95:529–535.
   PubMed Web of Science ®Google Scholar
• Mihara M, Uchiyama M. Determination of malonaldehyde precursor in tissues by thiobarbituric acid test. Anal Biochem. 1978;86(1):271–278.
   PubMed Web of Science ®Google Scholar
• Montgomery H, Dymock JFJA. Determination of nitrite in water. Royal Soc Chemistry Thomas Graham House, Science Park, Milton Rd, Cambridge; 1961. p. 414.
   Google Scholar
• Ellman GL. Tissue sulfhydryl groups. Arch Biochem Biophys. 1959;82(1):70–77.
   PubMed Web of Science ®Google Scholar
• Suzuki K, Ota H, Sasagawa S, et al. Assay method for myeloperoxidase in human polymorphonuclear leukocytes. Anal Biochem. 1983;132(2):345–352.
   PubMed Web of Science ®Google Scholar
• Keen JH, Habig WH, Jakoby WB. Mechanism for the several activities of the glutathione S-transferases. J Biol Chem. 1976;251(20):6183–6188.
   PubMed Web of Science ®Google Scholar
• Marklund S, Marklund G. Involvement of the superoxide anion radical in the autoxidation of pyrogallol and a convenient assay for superoxide dismutase. Eur J Biochem. 1974;47(3):469–474.
   PubMedGoogle Scholar
• Bancroft JD, Gamble M. Theory and practice of histological techniques. USA: Elsevier health sciences; 2008.
   Google Scholar
• Ramos-Vara J, Miller MJVp. When tissue antigens and antibodies get along: revisiting the technical aspects of immunohistochemistry-the red, brown, and blue technique. Vet Pathol. 2014;51(1):42–87.
   PubMed Web of Science ®Google Scholar
• Livak KJ, Schmittgen TDJm. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods. 2001;25(4):402–408.
   PubMed Web of Science ®Google Scholar
• Al Maruf A, O'Brien PJ, Naserzadeh P, et al. Methotrexate induced mitochondrial injury and cytochrome c release in rat liver hepatocytes. Drug Chem Toxicol. 2018;41(1):51–61.
   PubMed Web of Science ®Google Scholar
• El-Sayyad HI, Ismail MF, Shalaby FM, et al. Histopathological effects of cisplatin, doxorubicin and 5-flurouracil (5-FU) on the liver of male albino rats. Int J Biol Sci. 2009;5(5):466–473.
   PubMed Web of Science ®Google Scholar
• Zorzi D, Laurent A, Pawlik TM, et al. Chemotherapy-associated hepatotoxicity and surgery for colorectal liver metastases. Br J Surg. 2007;94(3):274–286.
   PubMed Web of Science ®Google Scholar
• Bu T, Wang C, Meng Q, et al. Hepatoprotective effect of rhein against methotrexate-induced liver toxicity. Eur J Pharmacol. 2018;834:266–273.
   PubMed Web of Science ®Google Scholar
• Pinar N, Kaplan M, Özgür T, et al. Ameliorating effects of tempol on methotrexate-induced liver injury in rats. Biomed Pharmacother. 2018;102:758–764.
   PubMed Web of Science ®Google Scholar
• Alturkistani HA, Abuzinadah OAH, Kelany AM, et al. The combined effect of honey and olive oil against methotrexate mediated hepatotoxicity in rats: A biochemical, histological and immunohistological study. Histol Histopathol. 2019;34(12):1313–1327.
   PubMed Web of Science ®Google Scholar
• Eki Nci-Akdemi RF, Yildirim S, Kandemi RFM, et al. The effects of casticin and myricetin on liver damage induced by methotrexate in rats. Iran J Basic Med Sci. 2018;21(12):1281–1288.
   PubMed Web of Science ®Google Scholar
• Hassanein EHM, Mohamed WR, Shalkami A-GS, et al. Renoprotective effects of umbelliferone on methotrexate-induced renal injury through regulation of Nrf-2/Keap-1, P38MAPK/NF-κB, and apoptosis signaling pathways . Food Chem Toxicol. 2018;116(Pt B):152–160.
   PubMedGoogle Scholar
• Vardi N, Parlakpinar H, Cetin A, et al. Protective effect of beta-carotene on methotrexate-induced oxidative liver damage. Toxicol Pathol. 2010;38(4):592–597.
   PubMed Web of Science ®Google Scholar
• Hassanein EHM, Shalkami A-GS, Khalaf MM, et al. The impact of Keap1/Nrf2, P38MAPK/NF-κB and Bax/Bcl2/caspase-3 signaling pathways in the protective effects of berberine against methotrexate-induced nephrotoxicity . Biomed Pharmacother. 2019;109:47–56.
   PubMed Web of Science ®Google Scholar
• Kim HJ, Kim JH, Moon W, et al. Rebamipide attenuates 5-Fluorouracil-induced small intestinal mucositis in a mouse model. Biol Pharm Bull. 2015;38(2):179–183.
   PubMed Web of Science ®Google Scholar
• Ohashi Y, Aihara E, Takasuka H, et al. Antral ulcers induced by alendronate, a nitrogen-containing biphophonate, in rat stomachs - prophylactic effect of rebamipide. J Physiol Pharmacol. 2009;60(3):85–93.
   PubMed Web of Science ®Google Scholar
• Ma Q. Role of nrf2 in oxidative stress and toxicity. Annu Rev Pharmacol Toxicol. 2013;53:401–426.
   PubMed Web of Science ®Google Scholar
• Wu KC, Cui JY, Klaassen CD. Beneficial role of Nrf2 in regulating NADPH generation and consumption. Toxicol Sci. 2011;123(2):590–600.
   PubMed Web of Science ®Google Scholar
• Jellestad L, Fink T, Pradarutti S, et al. Inhibition of glycogen synthase kinase (GSK)-3-β improves liver microcirculation and hepatocellular function after hemorrhagic shock . Eur J Pharmacol. 2014;724:175–184.
   PubMed Web of Science ®Google Scholar
• Guzik TJ, Korbut R, Adamek-Guzik T, et al. Nitric oxide and superoxide in inflammation and immune regulation. J Physiol Pharmacol. 2003;54(4):469–487.
   PubMed Web of Science ®Google Scholar
• Clancy RM, Amin AR, Abramson SB, et al. The role of nitric oxide in inflammation and immunity. Arthritis & Rheumatism. 1998;41(7):1141–1151.
   PubMedGoogle Scholar
• Archer S. Measurement of nitric oxide in biological models. Faseb J. 1993;7(2):349–360.
   PubMed Web of Science ®Google Scholar
• Abo-Haded HM, Elkablawy MA, Al-Johani Z, et al. Hepatoprotective effect of sitagliptin against methotrexate induced liver toxicity. PLoS One. 2017;12(3):e0174295.
   PubMed Web of Science ®Google Scholar
• Klebanoff SJ, Kettle AJ, Rosen H, et al. Myeloperoxidase: a front-line defender against phagocytosed microorganisms. J Leukoc Biol. 2013;93(2):185–198.
   PubMed Web of Science ®Google Scholar
• Pinar N,Çakırca G, Özgür T, et al. The protective effects of alpha lipoic acid on methotrexate induced testis injury  in rats. Biomed Pharmacother. 2018;97:1486–1492.
   PubMed Web of Science ®Google Scholar
• Mehrzadi S, Fatemi I, Esmaeilizadeh M, et al. Hepatoprotective effect of berberine against methotrexate induced liver toxicity in rats. Biomed Pharmacother. 2018;97:233–239.
   PubMed Web of Science ®Google Scholar
• Yan C, Deng C, Liu X, et al. TNF-α induction of IL-6 in alveolar type II epithelial cells: Contributions of JNK/c-Jun/AP-1 element, C/EBPδ/C/EBP binding site and IKK/NF-κB p65/κB site. Mol Immunol. 2018;101:585–596.
   PubMed Web of Science ®Google Scholar
• Bhoj VG, Chen ZJ. Ubiquitylation in innate and adaptive immunity. Nature. 2009;458(7237):430–437.
   PubMed Web of Science ®Google Scholar
• Li M, Zhang X, Wang B, et al. Effect of JAK2/STAT3 signaling pathway on liver injury associated with severe acute pancreatitis in rats. Exp Ther Med. 2018;16(3):2013–2021.
   PubMed Web of Science ®Google Scholar
• Rawlings JS, Rosler KM, Harrison DAJJocs. The JAK/STAT signaling pathway. J Cell Sci. 2004;117(Pt 8):1281–1283.
   PubMed Web of Science ®Google Scholar
• Jope RS, Johnson GV. The glamour and gloom of glycogen synthase kinase-3. Trends Biochem Sci. 2004;29(2):95–102.
   PubMed Web of Science ®Google Scholar
• Bode JG, Albrecht U, Häussinger D, et al. Hepatic acute phase proteins-regulation by IL-6- and IL-1-type cytokines involving STAT3 and its crosstalk with NF-κB-dependent signaling . Eur J Cell Biol. 2012;91(6-7):496–505.
   PubMed Web of Science ®Google Scholar
• Kotliarova S, Pastorino S, Kovell LC, et al. Glycogen synthase kinase-3 inhibition induces glioma cell death through c-MYC, nuclear factor-kappaB, and glucose regulation. Cancer Res. 2008;68(16):6643–6651.
   PubMed Web of Science ®Google Scholar
• Ougolkov AV, Bone ND, Fernandez-Zapico ME, et al. Inhibition of glycogen synthase kinase-3 activity leads to epigenetic silencing of nuclear factor kappaB target genes and induction of apoptosis in chronic lymphocytic leukemia B cells. Blood. 2007;110(2):735–742.
   PubMed Web of Science ®Google Scholar
• Li X-X, Jiang Z-H, Zhou B, et al. Hepatoprotective effect of gastrodin against alcohol-induced liver injury in mice. J Physiol Biochem. 2019;75(1):29–37.
   PubMed Web of Science ®Google Scholar
• Alhusaini A, Faddaa L, Ali HM, et al. Amelioration of the protein expression of Cox2, NFκB, and STAT-3 by some antioxidants in the liver of sodium fluoride-intoxicated rats. Dose Response. 2018;16(3):1559325818800153.
   Web of Science ®Google Scholar
• Chen L, Ren F, Zhang H, et al. Inhibition of glycogen synthase kinase 3β ameliorates D-GalN/LPS-induced liver injury by reducing endoplasmic reticulum stress-triggered apoptosis. PLoS One. 2012;7(9):e45202.
   PubMed Web of Science ®Google Scholar
• Xia Y-X, Lu L, Wu Z-S, et al. Inhibition of GSK-3beta ameliorates hepatic ischemia-reperfusion injury through GSK-3beta/beta-catenin signaling pathway in mice. Hepatobiliary Pancreat Dis Int. 2012;11(3):278–284.
   PubMed Web of Science ®Google Scholar
• Youle RJ, Strasser A. The BCL-2 protein family: opposing activities that mediate cell death. Nat Rev Mol Cell Biol. 2008;9(1):47–59.
   PubMed Web of Science ®Google Scholar
• Wang K. Autophagy and apoptosis in liver injury. Cell Cycle. 2015;14(11):1631–1642.
   PubMed Web of Science ®Google Scholar
• Kim H, Tu H-C, Ren D, et al. Stepwise activation of BAX and BAK by tBID, BIM, and PUMA initiates mitochondrial apoptosis. Mol Cell. 2009;36(3):487–499.
   PubMed Web of Science ®Google Scholar
• Ren D, Tu H-C, Kim H, et al. BID, BIM, and PUMA are essential for activation of the BAX- and BAK-dependent cell death program. Science. 2010;330(6009):1390–1393.
   PubMed Web of Science ®Google Scholar
• Wu S, Sa R, Gu Z, et al. The Protective Effect of Aesculus hippocastanum (Venoplant®) Against Concanavalin A-Induced Liver Injury. Pharmacology. 2019;104(3-4):196–206.
   PubMed Web of Science ®Google Scholar
• Fouad AA, Hafez HM, Hamouda A. Hydrogen sulfide modulates IL-6/STAT3 pathway and inhibits oxidative stress, inflammation, and apoptosis in rat model of methotrexate hepatotoxicity. Hum Exp Toxicol. 2020;39(1):77–85.
   PubMed Web of Science ®Google Scholar
• Owumi SE, Ajijola IJ, Agbeti OM. Hepatorenal protective effects of protocatechuic acid in rats administered with anticancer drug methotrexate. Hum Exp Toxicol. 2019;38(11):1254–1265.
   PubMed Web of Science ®Google Scholar